Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.
Address
Registered office address 4 Dorset Road, London, England, SE9 4QT
Work Hours
Monday to Friday: 7AM - 10PM
Weekend: 9AM - 8PM
Email Us
enquiries@vantixbio.co.uk.
The research peptide market has normalized 5mg BPC-157 vials based on packaging conventions rather than protocol-first study design. At Vantix Bio, we engineer vial sizes to match commonly used observation windows, not industry defaults.
Our BPC-157 10mg format supports typical multi-week research protocols from a single batch. No mid-study reordering. No interruption of data continuity. One vial, one complete observation window.
Preclinical rodent studies typically employ dosing ranges of 1-10 μg/kg over multi-week observation windows. For comprehensive tissue repair investigations—often designed to capture inflammatory response resolution timelines extending beyond 4 weeks—the material requirements quickly exceed what 5mg vials provide. The arithmetic is straightforward:
Extended multi-week protocols often require more than 5mg total peptide. The industry-standard 5mg vial may require reordering mid-study, forcing researchers to either:
Vantix Bio’s 10mg format eliminates this supply-demand mismatch. Researchers can execute complete multi-week observation windows with buffer remaining for reconstitution loss and transfer waste—variables every experienced researcher accounts for.
For researchers designing extended observation protocols, vial size becomes a design variable—not just a container. Aligning format with study duration removes a common source of protocol inconsistency.
| Feature | Industry Standard (5mg) | Vantix Bio (10mg) |
|---|---|---|
| Price per mg | £5.00-6.00/mg | £3.20/mg (37-47% savings) |
| Study capacity | 5mg total Limited extended studies | 10mg total Extended observation + buffer |
| Batch consistency | Requires 2 vials Batch variability risk | Single vial Eliminates variability |
| Purity verification | Generic COA (often batch-unverified) | Janoshik complementary-method Per-batch verification |
| Verification access | PDF only (if provided) | Live portal + session-linked watermarking Instant batch lookup |
Summary: The 10mg format delivers 37–47% lower cost per mg while reducing the need for mid-study reordering—a common source of batch variability in multi-week research protocols.
Every batch undergoes Janoshik complementary-method testing. View actual chromatograms and MS spectra before ordering.
BPC-157 is synthesized via solid-phase peptide synthesis (SPPS), the gold standard for peptide manufacturing. The Fmoc (fluorenylmethyloxycarbonyl) protection strategy enables sequential amino acid coupling with minimal deletion sequences or truncation artifacts.
Each batch undergoes:
Every Vantix Bio batch is tested through Janoshik-verified laboratories using two complementary analytical methods:
1. HPLC-DAD (High-Performance Liquid Chromatography with Diode Array Detection)
Quantifies purity by separating BPC-157 from impurities based on retention time. Our acceptance criterion: >99% purity with the target peptide peak representing >98% of total integrated area.
2. LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry)
Confirms molecular identity by measuring mass-to-charge ratio. Observed molecular weight must match theoretical MW (1419.53 g/mol for free acid) within typical LC-MS/MS precision. Tandem MS fragments the peptide to verify amino acid sequence integrity.
BPC-157 is a synthetic derivative of a gastric peptide sequence (Body Protective Compound) isolated from human gastric juice. While the exact endogenous receptor remains under investigation, preclinical research models suggest BPC-157 modulates several regenerative pathways:
Mechanism summary: BPC-157 modulates tissue repair pathways including angiogenesis, collagen synthesis, and inflammatory response in preclinical models. The following sections detail the specific pathways observed in laboratory studies.
In animal and in vitro models, BPC-157 has been shown to influence vascular endothelial growth factor (VEGF) expression, potentially accelerating blood vessel formation in damaged tissue. Enhanced vascularization in these systems may correlate with improved nutrient and oxygen delivery to repair sites.
In animal studies, the peptide appears to increase fibroblast migration and collagen deposition, particularly Type I collagen critical for tendon and ligament structural integrity.
Laboratory and animal studies indicate BPC-157 influences multiple growth factors including fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF), potentially coordinating the proliferative phase of tissue repair.
In research models, BPC-157 has been shown to influence nitric oxide (NO) pathways and may reduce pro-inflammatory cytokine expression, potentially shortening the inflammatory phase without completely suppressing the immune response needed for effective healing.
BPC-157 research spans multiple tissue types in laboratory and animal models, examining mechanisms including angiogenesis, collagen synthesis, and inflammatory modulation. Studies have utilized various dosing protocols in rodent models, typically in the 1-10 μg/kg range for multi-week observation windows.
Every BPC-157 10mg vial ships with a unique Batch ID printed on the label. This identifier links directly to Janoshik-verified laboratory test results through our verification portal.
This batch-level traceability ensures that the BPC-157 you’re studying is the same compound represented in the analytical report—not a generic COA from a different batch or supplier.
Unopened vials: Store at -20°C (freezer). Manufacturer guidance indicates lyophilized peptides generally remain stable for 24+ months when protected from moisture and light under these conditions.
Room temperature exposure: Common shipping conditions (2-3 days at ambient temperature) typically do not significantly degrade lyophilized BPC-157 based on standard peptide stability profiles. Prolonged storage above 25°C is not recommended.
Refrigerated (2-8°C): Standard laboratory practice suggests using reconstituted peptides within 2-4 weeks when stored in appropriate research diluent under refrigeration.
Frozen (-20°C): Extended stability may be possible, but freeze-thaw cycles can degrade peptides. Single-use aliquots are recommended if freezing reconstituted solution.
Batch consistency. When you complete a multi-week research protocol with material from a single batch, you reduce inter-batch variability as a potential confounding variable. Two 5mg vials from different production batches may have subtle purity differences (97.8% vs 98.4%) or slightly different residual solvent profiles—variables that can introduce noise into longitudinal data sets.
At £32 for 10mg, you’re paying £3.20/mg. Most suppliers charge £25–30 for 5mg vials (£5–6/mg)—a 37–47% higher cost per milligram. The 10mg format also reduces the need to source mid-study replacement vials from potentially different batches.
Our BPC-157 is supplied as the acetate salt, the form most commonly used in published preclinical research. The acetate counterion provides good solubility and stability for laboratory storage.
Yes. Visit our Verification Portal and enter any recent Batch ID from the “Recent Reports” section. You’ll see actual HPLC chromatograms and MS spectra from shipped batches. Every batch we sell undergoes identical third-party testing—what you see in recently shipped batches reflects what you’ll receive.
Explore additional analytical-grade research peptides and verification resources:
Janoshik-verified. Protocol-optimized sizing. Batch-level transparency.
Notify at Launch View Verification PortalBPC-157 is intended exclusively for in vitro research and analytical reference purposes. It is not approved for human consumption, therapeutic use, or clinical application. Researchers must ensure their studies comply with institutional review board requirements, animal care protocols (if applicable), and relevant regulatory frameworks.
As with all research peptides, proper documentation, storage, and handling procedures should follow institutional biosafety and chemical safety guidelines. The analytical-grade verification we provide supports compliance documentation and quality assurance requirements for research environments.
RESEARCH USE ONLY. All Vantix Bio products are analytical reference materials intended for in vitro laboratory research only. NOT for human or veterinary consumption, diagnostic use, or therapeutic application. These materials are not drugs and are not approved by the MHRA. Purchasers must be 21 years of age or older and certify qualified-researcher status at the point of purchase. Vantix Bio LLC
